Smith K - Search Results

1

Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.

Sheppard VB, Isaacs C, Luta G, Willey SC, Boisvert M, Harper FW, Smith K, Horton S, Liu MC, Jennings Y, Hirpa F, Snead F, Mandelblatt JS. Sheppard VB, et al. Among authors: smith k. Breast Cancer Res Treat. 2013 May;139(1):207-16. doi: 10.1007/s10549-013-2520-3. Epub 2013 Apr 16. Breast Cancer Res Treat. 2013. PMID: 23588954 Free PMC article.

2

Ethnic disparities in adjuvant chemotherapy for breast cancer are not caused by excess toxicity in black patients.

Smith K, Wray L, Klein-Cabral M, Schuchter L, Fox K, Glick J, DeMichele A. Smith K, et al. Clin Breast Cancer. 2005 Aug;6(3):260-6; discussion 267-9. doi: 10.3816/CBC.2005.n.029. Clin Breast Cancer. 2005. PMID: 16137438

3

Management of women at increased risk for hereditary breast cancer.

Smith KL, Isaacs C. Smith KL, et al. Breast Dis. 2006-2007;27:51-67. doi: 10.3233/bd-2007-27104. Breast Dis. 2006. PMID: 17917140 Review.

4

Practical aspects of delivering hereditary cancer risk counseling.

DeMarco TA, Smith KL, Nusbaum RH, Peshkin BN, Schwartz MD, Isaacs C. DeMarco TA, et al. Semin Oncol. 2007 Oct;34(5):369-78. doi: 10.1053/j.seminoncol.2007.07.003. Semin Oncol. 2007. PMID: 17920890 Review.

5

Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer.

Isaacs C, Herbolsheimer P, Liu MC, Wilkinson M, Ottaviano Y, Chung GG, Warren R, Eng-Wong J, Cohen P, Smith KL, Creswell K, Novielli A, Slack R. Isaacs C, et al. Among authors: smith kl. Breast Cancer Res Treat. 2011 Jan;125(1):137-43. doi: 10.1007/s10549-010-1226-z. Epub 2010 Oct 26. Breast Cancer Res Treat. 2011. PMID: 20976541 Free PMC article. Clinical Trial.

6

BRCA mutation testing in determining breast cancer therapy.

Smith KL, Isaacs C. Smith KL, et al. Cancer J. 2011 Nov-Dec;17(6):492-9. doi: 10.1097/PPO.0b013e318238f579. Cancer J. 2011. PMID: 22157293 Free PMC article. Review.

7

Deleterious BRCA1/2 mutations in an urban population of Black women.

Lynce F, Smith KL, Stein J, DeMarco T, Wang Y, Wang H, Fries M, Peshkin BN, Isaacs C. Lynce F, et al. Breast Cancer Res Treat. 2015 Aug;153(1):201-9. doi: 10.1007/s10549-015-3527-8. Epub 2015 Aug 7. Breast Cancer Res Treat. 2015. PMID: 26250392 Free PMC article.

8

Cardiac function in BRCA1/2 mutation carriers with history of breast cancer treated with anthracyclines.

Barac A, Lynce F, Smith KL, Mete M, Shara NM, Asch FM, Nardacci MP, Wray L, Herbolsheimer P, Nunes RA, Swain SM, Warren R, Peshkin BN, Isaacs C. Barac A, et al. Breast Cancer Res Treat. 2016 Jan;155(2):285-93. doi: 10.1007/s10549-016-3678-2. Epub 2016 Jan 9. Breast Cancer Res Treat. 2016. PMID: 26749359

9

Genomic profiling of breast cancer in African-American women using MammaPrint.

Nunes RA, Wray L, Mete M, Herbolsheimer P, Smith KL, Bijelic L, Boisvert ME, Swain SM. Nunes RA, et al. Breast Cancer Res Treat. 2016 Oct;159(3):481-8. doi: 10.1007/s10549-016-3949-y. Epub 2016 Aug 27. Breast Cancer Res Treat. 2016. PMID: 27568021

10

SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function.

Lynce F, Barac A, Tan MT, Asch FM, Smith KL, Dang C, Isaacs C, Swain SM. Lynce F, et al. Oncologist. 2017 May;22(5):518-525. doi: 10.1634/theoncologist.2016-0412. Epub 2017 Mar 17. Oncologist. 2017. PMID: 28314836 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13,992 results

Search Page